Yuchen Han

1.5k total citations · 1 hit paper
82 papers, 899 citations indexed

About

Yuchen Han is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yuchen Han has authored 82 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Yuchen Han's work include Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (22 papers) and Cancer Genomics and Diagnostics (16 papers). Yuchen Han is often cited by papers focused on Lung Cancer Treatments and Mutations (31 papers), Lung Cancer Diagnosis and Treatment (22 papers) and Cancer Genomics and Diagnostics (16 papers). Yuchen Han collaborates with scholars based in China, United States and Japan. Yuchen Han's co-authors include Ruiying Zhao, Chan Xiang, Jikai Zhao, Haohua Teng, Jinchen Shao, Lei Zhu, Yinan Ma, Lin Zhang, Runbo Zhong and Tianqing Chu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yuchen Han

75 papers receiving 891 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

2021 174 citations Tianqing Chu, Runbo Zhong et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuchen Han China	16	424	368	312	184	88	82	899
Naixin Liang China	14	437 1.0×	523 1.4×	248 0.8×	214 1.2×	64 0.7×	34	906
Yasir Y. Elamin United States	16	518 1.2×	595 1.6×	284 0.9×	164 0.9×	127 1.4×	68	968
Andrea Fontana Italy	19	335 0.8×	549 1.5×	285 0.9×	238 1.3×	153 1.7×	50	1.0k
Taoyuan Lu China	12	423 1.0×	261 0.7×	369 1.2×	332 1.8×	65 0.7×	25	812
Dengfeng Ren China	11	346 0.8×	535 1.5×	180 0.6×	149 0.8×	105 1.2×	47	825
Jia Luo United States	15	458 1.1×	528 1.4×	328 1.1×	288 1.6×	97 1.1×	64	1.0k
Martina Storz Switzerland	17	327 0.8×	326 0.9×	510 1.6×	255 1.4×	94 1.1×	23	935
Mateus Crespo United Kingdom	17	525 1.2×	421 1.1×	399 1.3×	393 2.1×	86 1.0×	44	1.0k
Yanqing Wang China	18	353 0.8×	291 0.8×	249 0.8×	195 1.1×	97 1.1×	30	740
Masato Sugano Japan	13	236 0.6×	427 1.2×	181 0.6×	117 0.6×	107 1.2×	44	709

Countries citing papers authored by Yuchen Han

Since Specialization

Citations

This map shows the geographic impact of Yuchen Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuchen Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuchen Han more than expected).

Fields of papers citing papers by Yuchen Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuchen Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuchen Han. The network helps show where Yuchen Han may publish in the future.

Co-authorship network of co-authors of Yuchen Han

This figure shows the co-authorship network connecting the top 25 collaborators of Yuchen Han. A scholar is included among the top collaborators of Yuchen Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuchen Han. Yuchen Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Yuchen, Mengting Li, Chen Tian, et al.. (2025). Berberine Alleviates Intestinal Inflammation by Disrupting Pathological Macrophage–Epithelial Crosstalk in Macrophage–Organoid Co-Culture Model. International Journal of Molecular Sciences. 26(20). 10161–10161. 1 indexed citations

Liu, Xiaoying, Rui Ren, Tao Sun, et al.. (2024). Constructing interfacial chemical interaction of dual-carbon protected cobalt diselenide anode for sodium storage. Chemical Engineering Journal. 496. 153790–153790. 17 indexed citations

Yang, Cheng, Jie Zhang, Yuchen Han, et al.. (2024). EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non–small cell lung cancer. Proceedings of the National Academy of Sciences. 121(23). e2317790121–e2317790121. 11 indexed citations

Xiang, Chan, Ke Chen, Ruiying Zhao, et al.. (2024). Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation. Modern Pathology. 37(4). 100451–100451. 9 indexed citations

Zhao, Ruiying, Yunhua Xu, Yedan Chen, et al.. (2023). Clonal dynamics and Stereo-seq resolve origin and phenotypic plasticity of adenosquamous carcinoma. npj Precision Oncology. 7(1). 80–80. 3 indexed citations

Li, Siwen, Zhichao Liu, Jikai Zhao, et al.. (2023). Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces. Lung Cancer. 177. 51–58. 19 indexed citations

Zhao, Lu, et al.. (2023). CoADS: Cross attention based dual-space graph network for survival prediction of lung cancer using whole slide images. Computer Methods and Programs in Biomedicine. 236. 107559–107559. 8 indexed citations

Yu, Yongfeng, et al.. (2023). Comprehensive molecular characterizations of stage I–III lung adenocarcinoma with tumor spread through air spaces. Frontiers in Genetics. 14. 1101443–1101443. 6 indexed citations

Li, Min, et al.. (2023). Thin-slice computed tomography enables to classify pulmonary subsolid nodules into pre-invasive lesion/minimally invasive adenocarcinoma and invasive adenocarcinoma: a retrospective study. Scientific Reports. 13(1). 6999–6999. 4 indexed citations

10.

Qian, Liqiang, Yinjie Zhou, Xiaoke Chen, et al.. (2022). A random forest algorithm predicting model combining intraoperative frozen section analysis and clinical features guides surgical strategy for peripheral solitary pulmonary nodules. Translational Lung Cancer Research. 11(6). 1132–1144. 6 indexed citations

11.

Zhang, Jing, Xiaoyan Jin, Xiaobing Zhang, et al.. (2022). Computed tomography versus frozen sections for distinguishing lung adenocarcinoma: A cohort study of concordance rate. Asian Journal of Surgery. 45(11). 2172–2178. 7 indexed citations

12.

Han, Yuchen, et al.. (2021). Challenging of frozen diagnoses of small sclerosing pneumocytoma. Journal of Clinical Pathology. 74(11). 730–734. 5 indexed citations

13.

Huo, Nan, Rui Cong, Wenchao Li, et al.. (2021). STAT3/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis. Cell Death and Disease. 12(9). 799–799. 69 indexed citations

14.

Han, Baohui, Tianqing Chu, Runbo Zhong, et al.. (2021). OA07.09 Sintilimab in Combination with Anlotinib as First-Line Therapy for Advanced NSCLC: Final Analysis of Primary Endpoints. Journal of Thoracic Oncology. 16(3). S119–S119.

15.

Zhao, Jikai, et al.. (2021). YAP1-MAML2 Fusion as a Diagnostic Biomarker for Metaplastic Thymoma. Frontiers in Oncology. 11. 692283–692283. 20 indexed citations

16.

Ku, Xin, Qiangling Sun, Lei Zhu, et al.. (2020). Deciphering tissue‐based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors. Molecular Oncology. 14(4). 721–741. 9 indexed citations

17.

Han, Yuchen, Li Pan, Jianying Zhang, et al.. (2020). Molecular and clinicopathological characteristics of ROS1‐rearranged non‐small‐cell lung cancers identified by next‐generation sequencing. Molecular Oncology. 14(11). 2787–2795. 26 indexed citations

18.

Shao, Jiaqi, et al.. (2020). [Issues on pathological diagnosis of bronchiolar adenoma].. PubMed. 49(6). 529–533. 4 indexed citations

19.

Yang, Zhangru, Mina Liu, Jiahua Yu, et al.. (2020). Treatment of stage III non-small cell lung cancer in the era of immunotherapy: pathological complete response to neoadjuvant pembrolizumab and chemotherapy. Translational Lung Cancer Research. 9(5). 2059–2073. 11 indexed citations

20.

Xiang, Chan, et al.. (2020). Molecular Profiling for Supernatants and Matched Cell Pellets of Pleural Effusions in Non–Small-Cell Lung Cancer. Journal of Molecular Diagnostics. 22(4). 513–522. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact